Invus Global Management, LLC - 13 Feb 2026 SCHEDULE 13G Report for Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
NMRA
Shares outstanding
166,626,333 shares
Disclosed Ownership
8,997,822 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
19 Feb 2026, 16:37:30 UTC
Date of event
13 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Invus Global Management, LLC disclosed 5.4% ownership in Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA) on 13 Feb 2026."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13G for Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA).
  • Disclosed ownership: 5.4%.
  • Date of event: 13 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 19 Feb 2026, 16:37.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 4.9% 8,172,814 8,172,814 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 4.9% 8,172,814 8,172,814 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 4.9% 8,172,814 8,172,814 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 4.9% 8,172,814 8,172,814 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 0.5% 825,008 825,008 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 0.5% 825,008 825,008 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 0.5% 825,008 825,008 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 5.4% 8,997,822 8,997,822 0 /s/ Raymond Debbane Raymond Debbane

Sponsored